AGP Executive Report
Last update: 4 hours agoFood Safety Alert: Hong Kong’s Centre for Health Protection is investigating suspected paralytic shellfish poisoning after a family ate whelk in Causeway Bay; symptoms began within about 30 minutes and one patient remains hospitalised in stable condition, with the toxin noted as heat-stable. Workplace Health & Safety: Labour Department enforcement continues after Phoenix Feast Group was fined $80,000 for failing to make statutory periodical compensation payments to an injured worker, while a separate heat-stress warning urges employers to assess risk and prevent heat stroke with shade, ventilation, and hydration/rest plans. COVID-19 Watch: Macau’s Health Bureau says local COVID-19 activity has risen above the warning threshold, with a weekly positivity rate of 17%, and urges high-risk groups to get vaccinated. Chronic Care in Focus: Kiang Wu Hospital opened a medically led weight management centre aimed at long-term chronic disease prevention and early intervention, not short-term weight loss. Health Tech & Pharma Moves: Antengene and K2 Therapeutics announced a licensing deal for ATG-106 (a CDH6 x CD3 bispecific T cell engager), and Kelun-Biotech reported translational results for sacituzumab tirumotecan plus osimertinib in first-line EGFR-mutant NSCLC published in Cancer Cell. Macao-Hengqin Integration: A report highlights growing Macao resident use of Hengqin’s cooperation zone for work and healthcare access, reflecting tighter cross-border living and services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.